Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy.

Autor: Perone F; Cardiac Rehabilitation Unit, Rehabilitation Clinic 'Villa delle Magnolie', 81020 Castel Morrone, Italy., Dentamaro I; Cardiology Department, Hospital of Policlinico of Bari, 70124 Bari, Italy., La Mura L; Department of Advanced Biomedical Sciences, University Federico II of Naples, 80133 Naples, Italy., Alifragki A; Department of Cardiology, University General Hospital of Heraklion, 71500 Crete, Greece., Marketou M; Department of Cardiology, University General Hospital of Heraklion, 71500 Crete, Greece., Cavarretta E; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso Della Repubblica, 79, 04100 Latina, Italy.; Mediterranea Cardiocentro, 80122 Napoli, Italy., Papadakis M; Department of Cardiology, St George's University, London SW170QT, UK., Androulakis E; Department of Cardiology, St George's University, London SW170QT, UK.; Cardiovascular Imaging Centre, Royal Brompton Hospital, Guy's and St Thomas NHS Foundation Trust, London SW3 6NP, UK.
Jazyk: angličtina
Zdroj: Journal of clinical medicine [J Clin Med] 2024 Feb 09; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 09.
DOI: 10.3390/jcm13041017
Abstrakt: Cardiac magnetic resonance (CMR) imaging has an important emerging role in the evaluation and management of patients with cardiomyopathies, especially in patients with dilated cardiomyopathy (DCM). It allows a non-invasive characterization of myocardial tissue, thus assisting early diagnosis and precise phenotyping of the different cardiomyopathies, which is an essential step for early and individualized treatment of patients. Using imaging techniques such as late gadolinium enhancement (LGE), standard and advanced quantification as well as quantitative mapping parameters, CMR-based tissue characterization is useful in the differential diagnosis of DCM and risk stratification. The purpose of this article is to review the utility of CMR in the diagnosis and management of idiopathic DCM, as well as risk prediction and prognosis based on standard and emerging CMR contrast and non-contrast techniques. This is consistent with current evidence and guidance moving beyond traditional prognostic markers such as ejection fraction.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje